Article ID Journal Published Year Pages File Type
10594066 Bioorganic & Medicinal Chemistry Letters 2011 4 Pages PDF
Abstract
Compound 11 displayed the most potent EGFR TK inhibitory activity with IC50 of 0.06 μM, which was comparable to the positive control. Molecular docking results indicated that compound 11 was nicely bound to the EGFR kinase with three hydrogen bonds. Compound 11 also showed significant antiproliferative activity against MCF-7 with IC50 of 0.07 μM, which would be a potential anticancer agent.
Related Topics
Physical Sciences and Engineering Chemistry Organic Chemistry
Authors
, , , , , ,